A simulated analysis in psoriasis highlights divergent patient and payer incentives and inconsistent coverage strategies behind barriers to phototherapy uptake.

Living with itchy, red, and scaly skin can feel like a constant battle that you are losing. You might feel embarrassed to wear short sleeves due to cosmetic concerns or frustrated because the itching ...

Learn how psoriasis, allergies, and eczema are connected and how they're different. Get lifestyle tips on managing both.

The Bicol Medical Center (BMC) on March 5 unveiled its newest medical equipment, the Excimer Laser, a specialized technology ...

Sarah Morrow receives funding from the National Institute for Health and Care Research (NIHR) and has previously received funding from the British Skin Foundation. For many people living with ...

From itchy skin to ongoing stress and anxiety, psoriasis symptoms can make getting a good night’s sleep difficult. As many as 50 percent of people with psoriasis have sleep problems at least once a ...

Zoryve (roflumilast) is a prescription drug that’s used to treat plaque psoriasis, atopic dermatitis, and seborrheic dermatitis in adults and certain children. Zoryve comes as a topical cream or ...

Researchers have figured out how psoriasis can quietly turn into joint disease for some patients. Immune cells formed in inflamed skin can travel through the blood and reach the joints, where they ...

Generalized pustular psoriasis (GPP) is the rarest form of psoriasis, a chronic autoimmune skin condition. Unlike other forms, GPP can be severe or even life-threatening. The disease causes flares of ...

Tildrakizumab effectively manages psoriasis in difficult-to-treat areas, showing high PASI75 and PASI90 response rates by week 104. Both 100-mg and 200-mg doses demonstrated comparable long-term ...

Please provide your email address to receive an email when new articles are posted on . Approximately 80% of the 60 million people worldwide with psoriasis also have overweight or obesity. Weight-loss ...

Dec 18 (Reuters) - Japan's Takeda Pharmaceutical (4502.T), opens new tab said on Thursday its experimental pill for a type of skin disease, developed using artificial intelligence, succeeded in two ...